Development of a RT-LAMP assay for detection of SARS-CoV-2

BACKGROUND & OBJECTIVES: The pandemic of SARS-COV-2 began in Wuhan, China in December 2019 and has caused more than 101 million cases worldwide. Diagnostic technologies possessing sensitivity and specificity equivalent to real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) assays...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandi, Shyam Sundar, Lambe, Upendra Pradeep, Sawant, Sonali Ankush, Gohil, Trupti, Deshpande, Jagadish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552371/
https://www.ncbi.nlm.nih.gov/pubmed/35313427
http://dx.doi.org/10.4103/ijmr.IJMR_713_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552371/
https://www.ncbi.nlm.nih.gov/pubmed/35313427
http://dx.doi.org/10.4103/ijmr.IJMR_713_21

Ejemplares similares